Vitamin K Antagonist Versus Direct Oral Anticoagulant Treatments in Hemophilia

CompletedOBSERVATIONAL
Enrollment

54

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Hemophilia AHemophilia BAnticoagulant-induced Bleeding
Interventions
DRUG

Vitamin K Antagonist - Drug

"Only clinical data (number and types of severe bleeding events, HAS-BLED score, CHA2DS2-VASc score) are collected during the follow-up:~* For cases when they received an anticoagulant treatment and during the 12 months preceding this treatment,~* For controls during the same periods of their cross-matched cases when reciving anticoagulant treatment."

Trial Locations (6)

14033

Hemophilia treatment center of caen, Caen

29609

Hemophilia treatment center of Brest, Brest

35033

Hemophilia treatment center of Rennes, Rennes

44093

Hemophilia treatment center of Nantes, Nantes

72037

Hemophilia treatment center of Le Mans, Le Mans

76000

Hemophilia treatment center of Rouen, Rouen

All Listed Sponsors
lead

Groupe Maladies hémorragiques de Bretagne

OTHER